Abstract:To investigate the clinical efficacy of Yupingfeng Dripping Pills combined with budesonide on the duration of adult asthma.Methods:A total of 100 adult patients with asthma duration treated in The Central Hospital of Enshi Autonomous Prefecture from June 2015 to November 2017 were selected and divided into control group and observation group according to different treatment methods,with 50 cases in each group.Patients in the control group were treated with budesonide formoterol powder inhaler,and based on the same treatment,the observation group was given Yupingfeng Dripping Pills.After 6 months' continuous treatment,the clinical effects,ACQ scores,and the number of acute attacks and the improvement of pulmonary function such as PEF and FEV1 in the 2 groups were statistically analyzed and compared.Results:The effective rate was 94.0% in observation group,which was significant higher than that of control group (80.0%).The difference was statistically significant (χ2=8.662,P=0.004).The numbers of acute exacerbations were (10.08±2.68) in the observation group and (15.23±2.77) in the control group after 6 months' treatment,and it was statistically significant (t=9.453,P=0.013).After treatment,ACQ scores were (1.21±0.28) points in the observation group and (1.67±0.31) points in the control group.The ACQ score was statistically significant (t=7.791,P=0.022).After treatment,PEF was (4.18±0.68) L/s in the observation group and (3.23±0.57) L/s in the control group.And the difference was statistically significant (t=7.577,P=0.033).The FEV1 was (2.81±0.48) L in the observation group and (2.07±0.31) L in the control group.After analysis,the difference was statistically significant (t=9.163,P=0.018).Conclusion:Yupingfeng Dripping Pill combined with budesonide can effectively relieve symptoms of asthma,reduce acute asthma attack,and effectively improve the lung function of patients,which is worthy for promotion in clinical practice.